Liquid biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026

Table of Content

1. Key Insights

2. Executive Summary of Liquid Biopsy in Cancer Diagnostics

3. Liquid Biopsy in Cancer Diagnostics: Background and Overview
3.1. Introduction
3.2. Types of Liquid Biopsy in Cancer Diagnostics
3.3. Advantages of Liquid Biopsy in Cancer Diagnostics
3.4. Disadvantages of Liquid Biopsy in Cancer Diagnostics

4. Liquid Biopsy in Cancer Diagnostics: Regulatory Scenario

5. Liquid Biopsy in Cancer Diagnostics: Reimbursement Scenario

6. Company Profiles
6.1. Lucence
6.1.1. Company Overview
6.1.2. Product Portfolio
6.1.2.1. Product description
6.1.2.2. Regulatory Milestones
6.1.2.3. Research and Development
6.1.2.4. Product Development Activities
6.2. Guardant Health
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.2.1. Product description
6.2.2.2. Regulatory Milestones
6.2.2.3. Research and Development
6.2.2.4. Product Development Activities
More Companies in the final report?

7. Liquid Biopsy in Cancer Diagnostics: Competitive Analysis

8. KOL Views

9. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM
9.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by Sample Type (2018–2026)
9.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by Technique (2018–2026)
9.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by Biomarker Type (2018–2026)
9.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in 7MM by End User (2018–2026)

10. Country-Wise Market size of Liquid Biopsy in Cancer Diagnostics in 7MM (2018–2026)
10.1. Market size of Liquid Biopsy in Cancer Diagnostics in the United States
10.1.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Sample Type (2018–2026)
10.1.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Technique (2018–2026)
10.1.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Biomarker Type (2018–2026)
10.1.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by End User (2018–2026)
10.2. Market size of Liquid Biopsy in Cancer Diagnostics in Germany
10.2.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Germany by Sample Type (2018–2026)
10.2.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Germany by Technique (2018–2026)
10.2.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in the United States by Biomarker Type (2018–2026)
10.2.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Germany by End User (2018–2026)
10.3. Market size of Liquid Biopsy in Cancer Diagnostics in France
10.3.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by Sample Type (2018–2026)
10.3.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by Technique (2018–2026)
10.3.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by Biomarker Type (2018–2026)
10.3.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in France by End User (2018–2026)
10.4. Market size of Liquid Biopsy in Cancer Diagnostics in Spain
10.4.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by Sample Type (2018–2026)
10.4.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by Technique (2018–2026)
10.4.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by Biomarker Type (2018–2026)
10.4.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Spain by End User (2018–2026)
10.5. Market size of Liquid Biopsy in Cancer Diagnostics in Italy
10.5.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by Sample Type (2018–2026)
10.5.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by Technique (2018–2026)
10.5.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by Biomarker Type (2018–2026)
10.5.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Italy by End User (2018–2026)
10.6. Market size of Liquid Biopsy in Cancer Diagnostics in UK
10.6.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Sample Type (2018–2026)
10.6.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Technique (2018–2026)
10.6.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Biomarker Type (2018–2026)
10.6.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by End User (2018–2026)
10.7. Market size of Liquid Biopsy in Cancer Diagnostics in Japan
10.7.1. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Japan by Sample Type (2018–2026)
10.7.2. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Japan by Technique (2018–2026)
10.7.3. Liquid Biopsy in Cancer Diagnostics: Market Analysis in UK by Biomarker Type (2018–2026)
10.7.4. Liquid Biopsy in Cancer Diagnostics: Market Analysis in Japan by End User (2018–2026)

11. Market Dynamics
11.1. Market Drivers
11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix
14.1. Bibliography
14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Figures

Figure 1: Competitive Analysis
Figure 2: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM (2018–2026)
Figure 3: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Sample Type (2018–2026)
Figure 4: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Technique (2018–2026)
Figure 5: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Biomarker Type (2018–2026)
Figure 6: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by End User (2018–2026)
Figure 7: Liquid Biopsy in Cancer Diagnostics United States Market Analysis (2018–2026)
Figure 8: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Sample Type (2018-2026)
Figure 9: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Technique (2018-2026)
Figure 10: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Biomarker Type (2018–2026)
Figure 11: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by End User (2018-2026)
Figure 12: Liquid Biopsy in Cancer Diagnostics Germany Market Analysis (2018–2026)
Figure 13: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Sample Type (2018-2026)
Figure 14: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Technique (2018-2026)
Figure 15: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Biomarker Type (2018–2026)
Figure 16: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by End User (2018-2026)
Figure 17: Liquid Biopsy in Cancer Diagnostics France Market Analysis (2018–2026)
Figure 18: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Sample Type (2018-2026)
Figure 19: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Technique (2018-2026)
Figure 20: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Biomarker Type (2018–2026)
Figure 21: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by End User (2018-2026)
Figure 22: Liquid Biopsy in Cancer Diagnostics Spain Market Analysis (2018–2026)
Figure 23: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Sample Type (2018-2026)
Figure 24: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Technique (2018-2026)
Figure 25: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Biomarker Type (2018–2026)
Figure 26: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by End User (2018-2026)
Figure 27: Liquid Biopsy in Cancer Diagnostics Italy Market Analysis (2018–2026)
Figure 28: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Sample Type (2018-2026)
Figure 29: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Technique (2018-2026)
Figure 30: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Biomarker Type (2018–2026)
Figure 31: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by End User (2018-2026)
Figure 32: Liquid Biopsy in Cancer Diagnostics United Kingdom Market Analysis (2018–2026)
Figure 33: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Sample Type (2018-2026)
Figure 34: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Technique (2018-2026)
Figure35: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Biomarker Type (2018–2026)
Figure 36: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by End User (2018-2026)
Figure 37: Liquid Biopsy in Cancer Diagnostics Japan Market Analysis (2018–2026)
Figure 38: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Sample Type (2018-2026)
Figure 39: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Technique (2018-2026)
Figure 40: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Biomarker Type (2018–2026)
Figure 41: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by End User (2018-2026)
Figure 34: Market Drivers
Figure 35: Market Barriers

List of Tables

Table 1: Competitive Analysis
Table 2: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM (2018–2026)
Table 3: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Sample Type (2018–2026)
Table 4: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Technique (2018–2026)
Table 5: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by Biomarker Type (2018–2026)
Table 6: Liquid Biopsy in Cancer Diagnostics Market Analysis in the 7MM by End User (2018–2026)
Table 7: Liquid Biopsy in Cancer Diagnostics United States Market Analysis (2018–2026)
Table 8: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Sample Type (2018-2026)
Table 9: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Technique (2018-2026)
Table 10: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by Biomarker Type (2018–2026)
Table 11: Liquid Biopsy in Cancer Diagnostics Market Analysis in the US by End User (2018-2026)
Table 12: Liquid Biopsy in Cancer Diagnostics Germany Market Analysis (2018–2026)
Table 13: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Sample Type (2018-2026)
Table 14: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Technique (2018-2026)
Table 15: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by Biomarker Type (2018–2026)
Table 16: Liquid Biopsy in Cancer Diagnostics Market Analysis in Germany by End User (2018-2026)
Table 17: Liquid Biopsy in Cancer Diagnostics France Market Analysis (2018–2026)
Table 18: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Sample Type (2018-2026)
Table 19: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Technique (2018-2026)
Table 20: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by Biomarker Type (2018–2026)
Table 21: Liquid Biopsy in Cancer Diagnostics Market Analysis in France by End User (2018-2026)
Table 22: Liquid Biopsy in Cancer Diagnostics Spain Market Analysis (2018–2026)
Table 23: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Sample Type (2018-2026)
Table 24: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Technique (2018-2026)
Table 25: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by Biomarker Type (2018–2026)
Table 26: Liquid Biopsy in Cancer Diagnostics Market Analysis in Spain by End User (2018-2026)
Table 27: Liquid Biopsy in Cancer Diagnostics Italy Market Analysis (2018–2026)
Table 28: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Sample Type (2018-2026)
Table 29: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Technique (2018-2026)
Table 30: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by Biomarker Type (2018–2026)
Table 31: Liquid Biopsy in Cancer Diagnostics Market Analysis in Italy by End User (2018-2026)
Table 32: Liquid Biopsy in Cancer Diagnostics United Kingdom Market Analysis (2018–2026)
Table 33: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Sample Type (2018-2026)
Table 34: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Technique (2018-2026)
Table35: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by Biomarker Type (2018–2026)
Table 36: Liquid Biopsy in Cancer Diagnostics Market Analysis in the UK by End User (2018-2026)
Table 37: Liquid Biopsy in Cancer Diagnostics Japan Market Analysis (2018–2026)
Table 38: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Sample Type (2018-2026)
Table 39: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Technique (2018-2026)
Table 40: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by Biomarker Type (2018–2026)
Table 41: Liquid Biopsy in Cancer Diagnostics Market Analysis in Japan by End User (2018-2026)